EYPT vs MELI · rev $1.2M vs P/E 43, rev $19.01B
Eyepoint Pharmaceuticals Inc (EYPT) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
EYPT currently screens at market cap $1.10B. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the EYPT and MELI stock pages for the full models.
Not investment advice.